Dan Brennan Analyst PerformanceSenior Equity Research Analyst - Managing Director at TD CowenDan Brennan is a stock analyst at TD Cowen, covering 7 publicly traded companies across a range of sectors. Over the past year, Dan Brennan has issued 6 stock ratings, including buy and hold recommendations. While full access to Dan Brennan's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Dan Brennan's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings8 Last 3 YearsBuy Recommendations85.71% 6 Buy RatingsCompanies Covered7 Unique Companies Ratings Distribution7RatingsDistribution of strong buy, buy, hold, and sell ratings by Dan Brennan.RatingPercentageCount Strong Buy0.0%0 ratings Buy85.7%6 ratings Hold14.3%1 ratings Sell0.0%0 ratingsOut of 7 total stock ratings issued by Dan Brennan at TD Cowen, the majority (85.7%) have been Buy recommendations, followed by 14.3% Hold.Best & Worst CallsBest Call000.0%AVTRDec 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ71.4% of companies on NASDAQ5 companiesNYSE28.6% of companies on NYSE2 companiesDan Brennan, an analyst at TD Cowen, currently covers 7 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical6 companies85.7%Transportation1 company14.3%Dan Brennan of TD Cowen specializes in stock coverage within the Medical sector, with additional focus on Transportation companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE2 companies28.6%MEDICAL SERVICES2 companies28.6%EQUIPMENT RENTAL & LEASING1 company14.3%MED PRODUCTS1 company14.3%MEDICAL INFO SYS1 company14.3% About Dan BrennanAt TD Cowen, Dan is responsible for providing research coverage on a diverse group of companies across the Life Science & Diagnostics Tools’ industry. This includes identifying key investment debates, building financial models, generating research reports, including ‘Ahead of the Curve’ deep dive analysis, making stock recommendations and engaging with clients and TD Cowen representatives. Daniel Brennan is a senior analyst covering Life Science & Diagnostic Tools. Prior to joining TD Cowen, Dan was a Managing Director and senior Life Science & Diagnostic Tools analyst at UBS. Prior to UBS, he was a senior health care analyst at Columbus Circle Investors. Dan also spent 19 years at Morgan Stanley, where he served, amongst other roles, as the health care sector equity sales specialist and later as the senior Life Science & Diagnostic Tools analyst. Mr. Brennan holds a BA in economics from Georgetown University, and an MBA from Harvard University. He is also a CFA® charterholder.Follow on LinkedIn Dan Brennan's Ratings History at TD Cowen Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Time Frame Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsADPTAdaptive Biotechnologies8/6/2025Boost Price Target$11.54$15.00Buy$0.0000.00% ROICAICAI International7/14/2025Initiated Coverage$26.51$32.00Buy$0.0000.00% ROIGHGuardant Health5/1/2025Boost Price Target$48.06$60.00Buy$0.0000.00% ROIWGSGeneDx5/1/2025Lower Price Target$64.88$110.00Buy$0.0000.00% ROIMRVIMaravai LifeSciences3/21/2025Lower Price Target$2.31$2.50Neutral$0.0000.00% ROITEMTempus AI2/5/2025Reiterated Rating$61.85$74.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.